Latest Profit Margins News

NTAW Holdings improved margins, reduced inventory and cut gross debt in FY2026, but remained loss-making as revenue fell sharply after the loss of key distribution rights. Management is targeting modest growth in FY2027 while covenant obligations and cash generation remain central tests.

Redox enters FY27 from a position of record revenue, higher margins and a debt-free balance sheet, while its North American business passes $100 million in sales. The chemical distributor also reported 9% higher average selling prices in the first quarter, although volumes remained broadly flat and freight costs increased.

Aspen Group delivered a stronger-than-expected first quarter, with net rental income up 16% and realised development profit nearly doubling to $7.9 million. The company maintained its FY27 targets, while warning that weaker economic conditions could disrupt development settlements.

Atlas Arteria has warned that France may more than double the tax rate applied to eligible toll-road operators, with APRR’s 2025 TEILD bill already reaching €126.7 million. The proposed changes remain subject to parliamentary debate and could be softened before becoming law.

Metal Powder Works has converted its first copper infiltration order into a two-year agreement worth approximately US$600,000, adding contracted demand ahead of its planned capacity expansion. Supply is scheduled to begin in January 2027.

Evion Group has moved its flagship Maniry graphite project into the development stage and secured a binding German offtake terms sheet, but its FY2026 accounts carry a material going concern warning. The company also faces an unpaid A$730,000 placement shortfall as it funds graphite, fluorspar and downstream expansion plans.

Blackpearl Group more than doubled annual recurring revenue to NZ$26.8 million in FY26, but the growth came alongside an NZ$17.8 million loss and a formal material uncertainty over its ability to continue as a going concern. The company says cost reductions, faster cash conversion and its refinanced BNZ facility can support the next phase.

Emyria has reported a sharp increase in FY26 revenue while expanding its psychedelic-assisted therapy network to five operational or announced clinics and 18 beds. Its first Sydney clinic is now fitted out and scheduled to begin treating patients in September, but utilisation and funding remain the next tests.

Pure Foods Tasmania reported a $8.78 million loss for FY26, largely driven by significant non-cash write-offs, while operational changes and acquisitions aim to stabilise growth.

Carma Limited posted a 59% revenue jump to $113.8 million in FY26, doubling gross profit to $10.5 million, while gearing up to double reconditioning capacity and target positive EBITDA in 2027.

United Overseas Australia Ltd (ASX:UOS) reported a 10.3% rise in half-year revenue to $124.65 million for the period ended 30 June 2026, while net profit after tax fell 7.7% to $41.17 million. The company announced a combined interim and special dividend totaling 2.0 cents per share.

Magontec Limited has reversed its recent losses with a 63% jump in half-year gross profit to $8.5 million and a net profit after tax of $1.1 million, driven by strong demand in electronic anodes and magnesium alloys.